Actively Recruiting

Phase Not Applicable
Age: 18Years - 100Years
All Genders
ID01621594

Prospective Evaluation of New Techniques in Radiation Reduction for Cardiovascular Computed Tomographic Angiography

Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2026-06-08

5000

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying new methods of cardiac CT angiography that use lower doses of radiation to create images of the heart and blood vessels. This study aims to find out if these low-dose imaging techniques are accurate and if they can predict heart-related outcomes. It also monitors the progression of coronary artery disease and evaluates updated cardiac imaging software and artificial intelligence compared to standard imaging. Participants will undergo a CT scan of the heart and blood vessels using the Cannon Aquilion ONE CT system, which is designed to reduce radiation exposure. The scan may include a contrast agent to improve image quality and can last up to 2 hours. Additional imaging may be done based on initial results to assess disease progression or late events. Participants will be evaluated through physical exams, medical history, and blood tests to check kidney function. Follow-up may occur via phone or office visits to track any further cardiovascular testing or events. Researchers will compare cardiovascular events among participants with different levels of artery narrowing and assess the accuracy and quality of new imaging techniques. The study will continue until 2027 and includes safety monitoring and long-term outcome tracking.

CONDITIONS

Brief Title

Evaluating New Radiation Techniques for Cardiovascular Imaging

Who Can Participate

Age: 18Years - 100Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Clinical indication for a coronary CT angiography exam
  • Age equal to or greater than 18 years
  • Able to understand and willing to sign the Informed Consent Form
  • Able and willing to provide follow-up information
Not Eligible

You will not qualify if you...

  • Pregnancy
  • Severe kidney dysfunction if receiving intravenous contrast, with estimated glomerular filtration rate below 30 mL/min/1.73m2

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Single day

Participants undergo coronary CT angiography using low-radiation dose CT technology to assess coronary artery disease and evaluate image quality with new CT techniques.

1 visit (in-person)

Long-term Monitoring

Duration - Up to several years

Participants are monitored over time to track cardiovascular events, progression of coronary plaques, and outcomes related to coronary artery disease.

Follow-up visits as requested by the ordering physician or as clinically indicated

Trial Site Locations

Total: 1 location

1

National Institutes of Health Clinical Center

Bethesda, Maryland, United States, 20892

Actively Recruiting

Loading map...

Research Team

M

Margaret C Lowery, R.N.

M

Marcus Y Chen, M.D.

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Similar Trials

ASSIST Trial Anatomic Versus Physiologic Guidance for Comple...

Coronary Disease

Actively Recruiting

17 locations

Change History and Adopt a Robotic Solution for Angioplasty ...

Coronary Disease

Actively Recruiting

8 locations

COMPLEX Registry: Prospective Study on Management and Outcom...

Coronary Disease

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Association of oxidized ApoB and oxidized ApoA-I with high-risk coronary plaque features in cardiovascular disease.

Alexander V Sorokin, Christin G Hong, Angel M Aponte...

https://pubmed.ncbi.nlm.nih.gov/37698922

Cell-free, high-density lipoprotein-specific phospholipid efflux assay predicts incident cardiovascular disease.

Masaki Sato, Edward B Neufeld, Martin P Playford...

https://pubmed.ncbi.nlm.nih.gov/37471145

Complex association of apolipoprotein E-containing HDL with coronary artery disease burden in cardiovascular disease.

Alexander V Sorokin, Nidhi Patel, Khaled M Abdelrahman...

https://pubmed.ncbi.nlm.nih.gov/35389891

Prospective evaluation of the influence of iterative reconstruction on the reproducibility of coronary calcium quantification in reduced radiation dose 320 detector row CT.

Andrew D Choi, Eric S Leifer, Jeannie Yu...

https://pubmed.ncbi.nlm.nih.gov/27591767